Barinthus Biotherapeutics PLBRNS

13F holders, Q3 2025 (September 30)
15holders +1
4new positions
3sold out
1famous investor
$1.13avg. 13F price*

At the end of Q3 2025, 15 institutions reported holding Barinthus Biotherapeutics PL (BRNS) in their 13F filings, up 1 from Q2 2025. 4 opened new positions and 3 sold out. The largest holders were M&G PLC ($5.2M), HSG Holding Ltd ($2.0M) and Alphabet Inc. ($1.9M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Barinthus Biotherapeutics PL
CUSIP
91864C107
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 15Q1 2024Q2 2024: 18Q2 2024Q3 2024: 19Q3 2024Q4 2024: 16Q4 2024Q1 2025: 15Q1 2025Q2 2025: 14Q2 2025Q3 2025: 15Q3 2025Q4 2025: 13Q4 2025Q1 2026: 14Q1 2026Q2 2026: 15Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions4$41K
Exits3$107K

All 13F filers, Q2 2025 → Q3 2025: 63,263 shares bought and 200,750 shares sold, net −137,487 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

M&G PLC 0.03% No change 5,197,349 $5.2M
HSG Holding Ltd 0.10% No change 1,420,473 $2.0M
Alphabet Inc. 0.08% No change 1,513,644 $1.9M
DC Funds, LP 25.81% No change 642,204 $803K
Johns Hopkins University 0.01% No change 122,237 $153K
Baird Financial Group, Inc. 0.00% Reduce -44.2% 107,461 $134K
Renaissance Technologies 0.00% Add +82.6% 66,300 $83K
HighTower Advisors, LLC 0.00% No change 37,450 $47K
HRT Financial LP 0.00% New 20,152 $25K
Janney Montgomery Scott LLC 0.00% No change 15,373 $19K
XTX Topco Ltd 0.00% New 13,007 $16K
Geode Capital Management, LLC 0.00% No change 11,568 $14K
Morgan Stanley 0.00% Add +1.9% 4,942 $6K
UBS Group AG 0.00% New 13 $16
SBI Securities Co., Ltd. 0.00% New 1 $1

"% of holder's portfolio" is BRNS's weight in each manager's 13F, not the share of Barinthus Biotherapeutics PL the manager owns.